Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2003
03/05/2003EP1286665A2 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
03/05/2003EP1286659A2 Macromolecular drug complexes and compositions containing the same
03/05/2003EP1202984B1 diphenyl-piperidine derivate
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1062214B1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels
03/05/2003EP0928197B1 Use of proteins as agents against autoimmune diseases
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
03/05/2003EP0833626B1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
03/05/2003EP0831830B1 Imidazole compounds
03/05/2003CN1400975A 嘌呤衍生物 Purine derivatives
03/05/2003CN1400973A Novel biarylcarboxamides
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400908A Combinations comprising dipeptidylpepidase IV inhibitors and antidiabetic agents
03/05/2003CN1400904A Selective estrogen receptor modulators in combination with estrogens
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400895A Remedies for degenerative arthritis
03/05/2003CN1400869A Inulin products with improved nutritional properties
03/05/2003CN1400012A Capsule and pill for curing pain due to hyperosteogeny and osteoarthritis disease and its preparation method
03/05/2003CN1400011A Chinese medicine ointment preparation for curing hyperosteogeny, pain and numbness and its production method
03/05/2003CN1400007A Oral Chinese medicine for curing osteoarthropathy
03/05/2003CN1399980A Adhesive plaster for curing osteomyelitis
03/05/2003CN1399977A Medicine for curing prolapse of lumbar intervertebral disc and its preparation method
03/05/2003CN1102400C Prolifration treating bolus
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/04/2003US6528681 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528619 Cyclic peptide binding inhibitors; structural formulas; use drugs for diseases mediated by urokinase and receptor; tumors; inflammation; angiogenesis
03/04/2003US6528533 Treating or preventing neuronal damage associated with neurological diseases; hydrazide based compounds containing the group -N-N-CO-X- where X is C,O,S,or N
03/04/2003US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation
03/04/2003US6528512 Cytokine specific binding protein;
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528493 Modulating activity of endogenous protein
03/04/2003US6528312 Nuclease inhibitor (G-Actin) or interleukin-10 (IL-10) use improving cell transfection; mixtures; polynucleotides; use gene therapy, vaccines
03/04/2003US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/01/2003WO2003000027A2 Blocking peptide for inflammatory cell secretion
03/01/2003CA2452123A1 Blocking peptide for inflammatory cell secretion
02/2003
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016567A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016544A1 Process for producing 1,4-dihydroxy-2-naphthoic acid
02/27/2003WO2003016528A2 Oligonucleotide compositions and their use to induce apoptosis
02/27/2003WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies
02/27/2003WO2003016341A2 Regulation of iron uptake
02/27/2003WO2003016335A2 Irreversible cysteine protease inhibitors of legumain
02/27/2003WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
02/27/2003WO2003016291A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
02/27/2003WO2003016279A1 Fused-polycyclic compounds
02/27/2003WO2003016277A1 Cyclohept`b!indole derivatives as spla2 inhibitors
02/27/2003WO2003016270A2 Selective estrogen receptor modulators
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/27/2003WO2003015822A1 5-cnac as oral delivery agent for parathyroid hormone fragments
02/27/2003WO2003015820A1 GnRH AGONIST COMBINATION DRUGS
02/27/2003WO2003015803A1 Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same
02/27/2003WO2003015802A1 Composition for treatment of articular cartilage damage
02/27/2003WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
02/27/2003WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
02/27/2003WO2003015794A1 Methods and compositions for treating apoptosis associated disorders
02/27/2003WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
02/27/2003WO2003015772A1 Inhibitors of polyq-aggregation
02/27/2003WO2003015770A1 Novel combination
02/27/2003WO2003015765A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
02/27/2003WO2003015761A1 Selective estrogen receptor modulators
02/27/2003WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
02/27/2003WO2003015751A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone
02/27/2003WO2003002123A3 Therapeutic combinations for the treatment of hormone deficiencies
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003WO2002099037A3 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
02/27/2003WO2002098354A3 Compositions and methods for inhibiting bone resorption
02/27/2003WO2002097046A3 B7 related protein-2 molecules and uses thereof
02/27/2003WO2002094180A3 Pharmaceutically active isoindoline derivatives
02/27/2003WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/27/2003WO2002090325A3 Benzazepinone alpha v integrin receptor antagonists
02/27/2003WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof
02/27/2003WO2002089740A3 Sulfonamides
02/27/2003WO2002087511A3 Modulators of elastase inhibitor secretion
02/27/2003WO2002066420A3 Tryptase inhibitors
02/27/2003WO2002064590A3 Carboline derivatives
02/27/2003WO2002058717A3 Methods for treating rheumatoid arthritis using il-17 antagonists
02/27/2003WO2002028865A3 Condensed pyridoindole derivatives
02/27/2003WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
02/27/2003WO2002009644A3 Angiogenic and osteogenic proteins for use in enhancing bone density and formation
02/27/2003WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
02/27/2003WO2002000691A3 Polynucleotides and polypeptides encoded thereby
02/27/2003WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
02/27/2003US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof
02/27/2003US20030040606 Reducing immunogenicities of immunoglobulins by framework-patching
02/27/2003US20030040541 Administering bismuth subgallate to inhibit the production of nitric oxide synthases (NOS)
02/27/2003US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease
02/27/2003US20030040535 Tetrazole compounds as thyroid receptor ligands
02/27/2003US20030040533 For use as hypoglycaemic and hypolipidaemic agents
02/27/2003US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity
02/27/2003US20030040517 For use in therapy of pain, fever, inflammation of a variety of conditions and diseases
02/27/2003US20030040513 P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
02/27/2003US20030040510 Selective estrogen receptor modulators in combination with estrogens
02/27/2003US20030040509 Methods and compositions for treating diseases associated with excesses in ACE
02/27/2003US20030040508 Altering the conformational equilibrium of the A- ring of a 1 alpha -hydroxylated vitamin D compound to favor a chair conformation for A-ring that presents the 1 alpha-hydroxyl in an axial orientation
1 ... 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 ... 820